Dyadic International, Inc. (DYAI)
| Previous Close | 1.4400 |
| Open | 1.4300 |
| Bid | 1.0700 x 200 |
| Ask | 1.9300 x 200 |
| Day's Range | 1.4300 - 1.5000 |
| 52 Week Range | 1.1900 - 2.4000 |
| Volume | |
| Avg. Volume | 22,465 |
| Market Cap | 43.855M |
| Beta (5Y Monthly) | 0.59 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2400 |
| Earnings Date | May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireDyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will report its financial results for the first quarter 2024 and host a corporate update conference call on
Insider MonkeyDyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript March 28, 2024 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. DYAI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good evening, and welcome […]
- Thomson Reuters StreetEvents
Q4 2023 Dyadic International Inc Earnings Call
Q4 2023 Dyadic International Inc Earnings Call
